Buprenorphine Black Cherry 2 mg Troche — Class II drug recall D-1054-2020
Terminated recall by Matthew 7:25 Inc dba Thrive Pharmacy, reported 2020-04-01, distributed in FL. Subpotent Drug
| Recall number | D-1054-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Matthew 7:25 Inc dba Thrive Pharmacy, Jacksonville, FL, United States |
| Recall initiated | 2020-03-10 |
| Classified | 2020-03-23 |
| Reported by FDA | 2020-04-01 |
| Terminated | 2023-06-02 |
| Distributed | FL |
| Quantity | 89 troches |
| Reason classes | potency |
| Lot numbers | 191217A |
| Expiration dates | 2020-06-14 |
Product
Buprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1054-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.